Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05699499 · ClinicalTrials.gov registry record · NA

Analysis of Impact of KeryFlex on Quality of Life for Retronychia or Lichen Planus Adult Patients

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT05699499 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05699499, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to assess the overall effect of KeryFlex study intervention on quality of life and functionality for patients with retronychia or nail lichen planus.

Interventions

  • OTHER KeryFlex

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-04-11
Est. Completion 2023-09-28
Phase NA

What the Registry Record Tells You About NCT05699499

The ClinicalTrials.gov registry entry for NCT05699499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which KeryFlex is the first listed.

NCT05699499 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05699499 about?

NCT05699499 is a clinical study titled "Analysis of Impact of KeryFlex on Quality of Life for Retronychia or Lichen Planus Adult Patients". The purpose of this study is to assess the overall effect of KeryFlex study intervention on quality of life and functionality for patients with retronychia or nail lichen planus.

What is the current status of trial NCT05699499?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-04-11. Estimated completion is 2023-09-28.

What interventions are being tested in trial NCT05699499?

The interventions under investigation include: KeryFlex (OTHER).

Who is sponsoring clinical trial NCT05699499?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.